Boltz Bio Joins AAlphaBio-Led AI Drug Discovery Data Consortium
GabriCorso · x · 2026-07-22
Boltz Bio announced it is a founding member of a new data consortium organized by AAlphaBio. The consortium includes major pharmaceutical and AI design companies such as GSK, Cradle Bio, and Dyno Therapeutics to advance AI-driven drug discovery.
Related event: Boltz Bio Joins AI Drug Discovery Data Consortium(4 posts)→
More from Companies & People
- AI lab staff have gone strangely quiet about next-year capability predictions — ChrisGPT · 2026-07-27
- Anthropic faces renewed culture backlash over alleged open-source AI screening — rdesh26 · 2026-07-27
- Tokyo Agent Forge hackathon shipped production-ready AI agents in one day — DavidBennett__ · 2026-07-27
- A high-school genius meme ends with four people at Anthropic — hingeloss · 2026-07-27
- Organizations may already be the planet’s superintelligences — eldonredwards · 2026-07-27
- AI demand comes from 300 million businesses, not circular-financing narratives — BenBajarin · 2026-07-27